Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Tetanus"
Show Display Options
Rank Status Study
1 Recruiting Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: DTaP-IPV combination vaccine;   Biological: DTaP vaccine and IPV vaccine
2 Not yet recruiting Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
Conditions: Tetanus;   Diphtheria;   Whooping Cough
Interventions: Biological: Biological: GC3111 vaccine;   Biological: Biological: Boostrix® vaccine
3 Not yet recruiting A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Conditions: Haemophilus Influenzae Type B Vaccines;   Diphtheria;   Hepatitis B;   Tetanus;   Pertussis
Intervention: Biological: Infanrix® -IPV/Hib
4 Not yet recruiting Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenza Type B
Intervention:
5 Recruiting Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Acellular Pertussis;   Tetanus;   Poliomyelitis;   Diphtheria
Interventions: Biological: Infanrix hexa;   Drug: Prevnar13
6 Not yet recruiting Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Diphtheria;   Hepatitis B;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Tetanus;   Poliomyelitis
Intervention: Biological: Infanrix hexa
7 Recruiting DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Polio;   Human Immunodeficiency Virus Infection
Intervention: Biological: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
8 Recruiting Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Influenzae Type b
Intervention: Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™)
9 Unknown  Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Intervention: Biological: Shan 5
10 Not yet recruiting Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program
Condition: Healthy
Intervention: Biological: Tetanus and Diphtheria (Td) Vaccine
11 Unknown  Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
12 Recruiting Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids™ Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix™ (GSK444563) in Healthy Infants
Condition: Rotavirus Vaccines
Interventions: Biological: Squarekids®;   Biological: Rotarix™
13 Recruiting Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Conditions: Diphtheria;   Acellular Pertussis;   Tetanus
Intervention: Other: Pertussis maternal immunization
14 Recruiting The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Conditions: Rotavirus Infections;   Intestinal Bacteria Flora Disturbance;   Reaction - Vaccine Nos;   Tetanus;   Streptococcal Pneumonia
Intervention: Biological: Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccine
15 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
Condition: Diphtheria-Tetanus-acellular Pertussis Vaccines
Interventions: Biological: Boostrix™;   Drug: Saline placebo
16 Not yet recruiting Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
Condition: Heterologous Effects of Vaccines
Interventions: Biological: Seasonal influenza vaccine;   Biological: Diphtheria-tetanus-acellular pertussis vaccine
17 Unknown  Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
Condition: Colorectal Cancer
Intervention: Biological: CEA pulsed dendritic cells
18 Recruiting Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma;   Malignant Glioma;   Astrocytoma, Grade IV;   GBM
Interventions: Biological: pp65-shLAMP DC with GM-CSF;   Biological: unpulsed PBMC and saline;   Drug: Td;   Drug: Saline;   Drug: pp65-flLAMP DC with GM-CSF
19 Recruiting DC Migration Study for Newly-Diagnosed GBM
Conditions: Glioblastoma;   Astrocytoma, Grade IV;   Giant Cell Glioblastoma;   Glioblastoma Multiforme
Interventions: Biological: Group I unpulsed DCs;   Biological: Group II Td;   Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs;   Biological: 111In-labeled DCs;   Drug: Temozolomide;   Drug: Saline;   Drug: Group III basiliximab and Td
20 Unknown  Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Condition: Malaria
Interventions: Biological: Malaria vaccine AMA1 (PfAMA-1-FVO[25-545];   Biological: AMA1

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years